Primary Focal Segmental Glomerulosclerosis Plasmas Increase Lipid Droplet Formation and Perilipin-2 Expression in Human Podocytes

Autor: Dirk J. W. den Braanker, Rutger J. H. Maas, Guido van Mierlo, Naomi M. J. Parr, Marinka Bakker-van Bebber, Jeroen K. J. Deegens, Pascal W. T. C. Jansen, Jolein Gloerich, Brigith Willemsen, Henry B. Dijkman, Alain J. van Gool, Jack F. M. Wetzels, Markus M. Rinschen, Michiel Vermeulen, Tom Nijenhuis, Johan van der Vlag

Publikováno v: International Journal of Molecular Sciences, 24
International Journal of Molecular Sciences, 24, 1
International Journal of Molecular Sciences; Volume 24; Issue 1; Pages: 194
den Braanker, D J W, Maas, R J H, van Mierlo, G, Parr, N M J, Bakker-van Bebber, M, Deegens, J K J, Jansen, P W T C, Gloerich, J, Willemsen, B, Dijkman, H B, van Gool, A J, Wetzels, J F M, Rinschen, M M, Vermeulen, M, Nijenhuis, T & van der Vlag, J 2023, ' Primary Focal Segmental Glomerulosclerosis Plasmas Increase Lipid Droplet Formation and Perilipin-2 Expression in Human Podocytes ', International Journal of Molecular Sciences, vol. 24, no. 1, 194 . https://doi.org/10.3390/ijms24010194

Many patients with primary focal segmental glomerulosclerosis (FSGS) develop recurrence of proteinuria after kidney transplantation. Several circulating permeability factors (CPFs) responsible for recurrence have been suggested, but were never valida

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c43e16077b71fa94ea8e2e34c10a539
https://doi.org/10.3390/ijms24010194

Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations?

Autor: Willem M. Ankum, Harold R. Verhoeve, Antonius B. Dijkman, L. van der Leeuw-Harmsen, F. van der Veen, M.H. Emanuel, J. P. Lips, Jaap Friederich, M. van Wely, M.A. van Kessel, Neriman Bayram, B.W. Mol, N.M. van Mello, Albert H. Adriaanse, Femke Mol, Erik A. Boss, Petra J. Hajenius

Publikováno v: van Mello, N M, Mol, F, Verhoeve, H R, van Wely, M, Adriaanse, A H, Boss, E A, Dijkman, A B, Bayram, N, Emanuel, M H, Friederich, J, van der Leeuw-Harmsen, L, Lips, J P, Van Kessel, M A, Ankum, W M, van der Veen, F, Mol, B W & Hajenius, P J 2013, ' Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations? A randomized comparison ', Human Reproduction, vol. 28, no. 1, pp. 60-7 . https://doi.org/10.1093/humrep/des373
Human Reproduction, 28(1), 60-7. Oxford University Press
Human reproduction (Oxford, England), 28(1), 60-67. Oxford University Press

STUDY QUESTION: What is the treatment success rate of systemic methotrexate (MTX) compared with expectant management in women with an ectopic pregnancy or a pregnancy of unknown location (PUL) with low and plateauing serum hCG concentrations?SUMMARY

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::993efacea740c08247db2c5bc16bc4b4
https://doi.org/10.1093/humrep/des373

Minimal invasive epicardial lead implantation: optimizing cardiac resynchronization with a new mapping device for epicardial lead placement☆

Autor: B. Dijkman, B. Phelps, Andre Dekker, Jos G. Maessen

Publikováno v: European Journal of Cardio-Thoracic Surgery. 25:894-896

To optimize resynchronization in biventricular pacing with epicardial leads, mapping to determine the best pacing site, is a prerequisite. A port access surgical mapping technique was developed that allowed multiple pace site selection and reproducib

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ef3abff19ef6d375af752bb30f25d5e
https://doi.org/10.1016/j.ejcts.2004.01.055

The METEX study: methotrexate versus expectant management in women with ectopic pregnancy: a randomised controlled trial

Autor: Antonius B. Dijkman, Loes van der Leeuw-Harmsen, Evert J.P. van Santbrink, M.H. Emanuel, Harry Visser, Ben W.J. Mol, Harold R. Verhoeve, Willem M. Ankum, Femke Mol, Johannes P.R. Doornbos, Erik A. Boss, Jaap Friederich, Norah M. van Mello, Albert H. Adriaanse, J. P. Lips, Petra J. Hajenius, Fulco van der Veen

Publikováno v: BMC Women's Health, 8. BioMed Central
BMC Women's health, 8(1). BioMed Central
van Mello, N M, Mol, F, Adriaanse, A H, Boss, E A, Dijkman, A B, Doornbos, J P, Emanuel, M H, Friederich, J, Leeuw-Harmsen, L V D, Lips, J P, van Santbrink, E J, Verhoeve, H R, Visser, H, Ankum, W M, Veen, F V D, Mol, B W & Hajenius, P J 2008, ' The METEX study : methotrexate versus expectant management in women with ectopic pregnancy: a randomised controlled trial ', BMC Women's Health, vol. 8, pp. 10 . https://doi.org/10.1186/1472-6874-8-10
BMC Womens Health, 8, 10-10. BioMed Central Ltd.
BMC Women's Health
BMC Women's Health, Vol 8, Iss 1, p 10 (2008)

Background Patients with ectopic pregnancy (EP) and low serum hCG concentrations and women with a pregnancy of unknown location (PUL) and plateauing serum hCG levels are commonly treated with systemic methotrexate (MTX). However, there is no evidence

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd6513f335593f633fba3c25e3cbbd09
https://doi.org/10.1186/1472-6874-8-10

Atrial therapies reduce atrial arrhythmia burden in defibrillator patients

Autor: Stephen C. Hammill, Rahul Mehra, M S Stanton, Paul A. Friedman, B Dijkman, Eduardo N. Warman, H A Xia

Publikováno v: Circulation. 104(9)

Background Approximately 25% of patients who receive an implantable cardioverter-defibrillator (ICD) to treat ventricular tachyarrhythmias have documented atrial tachyarrhythmias before implantation. This study assessed the ability of device-based pr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0d4135cfc73350d777649f4a430037b
https://pubmed.ncbi.nlm.nih.gov/11524396